Radiopharm Theranostics CEO Shares Company Milestones as NASDAQ Listing Nears
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting